Clinical Trials Sponsored by Sergio Bergese
Total 1277 results
-
Sergio BergeseCompletedNausea | Postoperative Nausea and Vomiting (PONV)United States
-
BeiGene USA, Inc.CompletedBrain and Central Nervous System TumorsUnited States, Netherlands, Switzerland
-
BeiGeneNot yet recruitingAutoimmune Diseases | Healthy Volunteers | Healthy Subjects | Healthy Participants | Healthy Adult Participants
-
BeiGeneRecruitingNon-Small Cell Lung CancerChina, Korea, Republic of
-
BeiGeneRecruitingEsophageal Cancer | Esophageal Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma by AJCC V8 StageChina, Taiwan, Korea, Republic of, Thailand
-
BeiGeneRecruitingWaldenstrom Macroglobulinemia | Waldenstrom's Macroglobulinemia Recurrent | Waldenstrom's Macroglobulinemia RefractoryUnited States, Australia, France, China, Spain, United Kingdom
-
BeiGeneRecruitingSolid Tumor | Advanced Solid Tumor | Metastatic Solid TumorUnited States, Australia
-
BeiGeneRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaChina, Italy, Taiwan, Australia, Spain, Korea, Republic of, France, Thailand, United States, Georgia, Singapore, Canada
-
BeiGeneRecruitingPrimary Membranous NephropathyChina, United Kingdom, United States
-
BeiGeneRecruitingWaldenstrom MacroglobulinemiaUnited States, Puerto Rico
-
BeiGeneRecruiting
-
BeiGeneRecruitingFollicular Lymphoma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Richter's Transformation | DLBCL UnclassifiableChina
-
BeiGeneRecruitingRelapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell LymphomaChina
-
BeiGeneRecruitingRelapsed/Refractory Multiple MyelomaUnited States, China, Australia, Korea, Republic of, United Kingdom, Canada, Brazil, New Zealand
-
BeiGeneRecruitingNSCLC | Non-small Cell Lung CancerJapan, United States, France, Mexico, Germany, Argentina, Brazil, Korea, Republic of, Turkey
-
BeiGeneRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Advanced Solid Tumor | Diffuse Large B Cell Lymphoma | Small Lymphocytic LymphomaAustralia, China
-
BeiGeneRecruiting
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
-
BeiGeneCompletedRelapsed/Refractory Diffuse Large B-Cell LymphomaChina
-
BeiGeneCompleted
-
BeiGeneActive, not recruitingLocally Advanced and Metastatic Solid TumorsChina, Taiwan, United States, Australia
-
BeiGeneCompletedAdvanced Hepatocellular CarcinomaChina, Taiwan
-
BeiGeneEnrolling by invitationAdvanced MalignanciesChina, Taiwan, Korea, Republic of, Turkey
-
BeiGeneCompletedTriple Negative Breast Cancer | Advanced High-grade Ovarian CancerChina
-
BeiGeneActive, not recruitingGastric, or Gastroesophageal Junction AdenocarcinomaUnited States, China, Spain, Korea, Republic of, Poland, Russian Federation, Taiwan, France, Turkey, Japan, Italy, United Kingdom, Puerto Rico
-
BeiGeneTerminatedNon Small Cell Lung CancerChina, Taiwan, Australia, United States
-
BeiGeneActive, not recruiting
-
BeiGeneActive, not recruiting
-
BeiGeneCompletedEsophageal Squamous Cell Carcinoma (ESCC)Spain, United States, United Kingdom, China, Taiwan, Korea, Republic of, Japan, France, Germany, Belgium, Italy
-
BeiGeneCompleted
-
BeiGeneActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, China, Taiwan, Belgium, France, United Kingdom, Spain, New Zealand, Australia, Czechia, Italy, Poland, Russian Federation, Sweden, Austria
-
BeiGeneCompletedCervical CancerKorea, Republic of, Taiwan, China, Thailand, Poland, Bulgaria, Russian Federation, Ukraine
-
BeiGeneEnrolling by invitationB-cell MalignanciesSpain, United Kingdom, China, United States, Australia, Netherlands, Italy, Sweden, Czechia, New Zealand, Greece, Germany, Poland
-
BeiGeneActive, not recruitingNonsmall Cell Lung Cancer, Stage IV | Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC)United States, China, Korea, Republic of, France, Spain, Australia, Austria
-
BeiGeneActive, not recruitingRecurrent or Metastatic Nasopharyngeal CancerChina, Taiwan, Thailand
-
BeiGeneActive, not recruiting
-
BeiGeneCompletedSolid TumorGeorgia, Moldova, Republic of, Poland, Slovakia
-
BeiGeneCompletedLymphoma | LeukemiaChina, Australia
-
BeiGeneCompletedCovid19United States, Mexico, Brazil, South Africa
-
BeiGeneCompletedWaldenström's Macroglobulinemia (WM)China
-
BeiGeneCompletedDiffuse Large B-cell LymphomaChina
-
BeiGeneCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Marginal Zone LymphomaChina
-
BeiGeneCompletedFor Participants With Advanced Solid Tumors Failed With Previous Lines of TreatmentAustralia
-
BeiGeneCompleted
-
BeiGeneCompletedHealthy Volunteers: Asian, Non-AsianUnited States
-
BeiGeneRecruitingNon-small Cell Lung CancerChina, Georgia, Moldova, Republic of
-
BeiGeneRecruitingAdvanced Solid TumorsUnited States, Australia, Spain
-
BeiGeneRecruitingMelanoma | Renal Cell Carcinoma | Urothelial CarcinomaChina
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, China, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina